Labeler
Sandoz Inc NDC Codes
Sandoz Inc lists 432 finished drug products in the FDA NDC Directory under NDC labeler codes 0781, 61314.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexmethylphenidate Hydrochloride Extended-Release, Lisdexamfetamine dimesylate, Hyrimoz, Pomalidomide, Adalimumab, Bumetanide, Sitagliptin Phosphate, Iron Sucrose, Pyzchiva, Cyclophosphamide, Pirfenidone, Pemetrexed, Phenylephrine Hydrochloride, Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride, Sugammadex
- Active ingredients
- Dexmethylphenidate hydrochloride, Adalimumab, Lisdexamfetamine dimesylate, Sitagliptin phosphate, Pomalidomide, Bumetanide, Iron sucrose, Ustekinumab, Cyclophosphamide, Pirfenidone, Pemetrexed disodium, Phenylephrine hydrochloride
- NDC labeler codes
- 0781, 61314
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Phenylephrine hydrochloride 10 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Adalimumab 10 mg/.1mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Fulvestrant 50 mg/mL; Adalimumab 40 mg/.4mL; Pirfenidone 267 mg/1; Acetaminophen 10 mg/mL; Dexmethylphenidate hydrochloride 25 mg/1; Dexmethylphenidate hydrochloride 30 mg/1; Dexmethylphenidate hydrochloride 35 mg/1; Dexmethylphenidate hydrochloride 40 mg/1; Dexmethylphenidate hydrochloride 5 mg/1; Dexmethylphenidate hydrochloride 10 mg/1; Dexmethylphenidate hydrochloride 15 mg/1; Dexmethylphenidate hydrochloride 20 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1
- Dosage forms
- Injection, Solution, Injection, Capsule, Tablet, Film coated, Capsule, Extended release, Tablet, Suspension/ drops, Injection, Solution, Concentrate, Solution/ drops, Kit, Injection, Powder, Lyophilized, For solution, Concentrate, Injection, Powder, For solution, Injection, Powder, Lyophilized, For suspension, Aerosol, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Intravitreal, Intramuscular, Parenteral, Respiratory (Inhalation), Auricular (Otic)
- Drug classes (FDA established)
- Central Nervous System Stimulant, Tumor Necrosis Factor Blocker, Parenteral Iron Replacement, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Phosphate Binder, Loop Diuretic, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Pyridone, Folate Analog Metabolic Inhibitor, alpha-1 Adrenergic Agonist, Central alpha-2 Adrenergic Agonist, Aminosalicylate, Corticosteroid, Sodium-Glucose Cotransporter 2 Inhibitor, Kinase Inhibitor, Biguanide, Microtubule Inhibitor, Serotonin-4 Receptor Agonist, RANK Ligand Inhibitor, Vascular Endothelial Growth Factor Inhibitor, alpha-Adrenergic Agonist, Estrogen Receptor Antagonist, Phenothiazine, Macrolide Antibacterial, Purine Antimetabolite, Proton Pump Inhibitor, Integrin Receptor Antagonist, Endothelin Receptor Antagonist, Barbiturate, Methylxanthine, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Nucleoside Metabolic Inhibitor, Prostaglandin Analog, beta-Adrenergic Blocker, Penicillin-class Antibacterial, beta Lactamase Inhibitor, beta2-Adrenergic Agonist, Carbonic Anhydrase Inhibitor, Fluoroquinolone Antibacterial
- HCPCS / J-code
- J1756 — Injection, iron sucrose, 1 mg, J0897 — Injection, denosumab, 1 mg, J0135 — Injection, adalimumab, 20 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J2778 — Injection, ranibizumab, 0.1 mg, J0131 — Injection, acetaminophen, 10 mg
- Package NDCs
- 140 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Infuvite Adultmultiple vitamins injection | — | Kit | 54643-5649 | 54643-5649-01 | — |
| Ceftriaxone Sodium | Ceftriaxone sodium 10 g/100mL | Injection, Powder, For solutionIntravenous | 0781-3210 | 00781-3210-46 | J0696 |
| Regonolpyridostigmine bromide | Pyridostigmine bromide 5 mg/mL | Injection, SolutionIntravenous, Parenteral | 0781-3040 | 00781-3040-95 | — |
| Ceftriaxone Sodium | Ceftriaxone sodium 250 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-3206 | 00781-3206-8500781-3206-95 | J0696 |
| Ceftriaxone Sodium | Ceftriaxone sodium 500 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-3207 | 00781-3207-8500781-3207-95 | J0696 |
| Ceftriaxone Sodium | Ceftriaxone sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-3208 | 00781-3208-8500781-3208-95 | J0696 |
| Ceftriaxone Sodium | Ceftriaxone sodium 2 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-3209 | 00781-3209-95 | J0696 |
| Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin monohydrate 75 mg/1; Nitrofurantoin 25 mg/1 | CapsuleOral | 0185-0122 | 00185-0122-0100185-0122-10 | — |
| Ciprofloxacin Hydrochloride | Ciprofloxacin hydrochloride 3 mg/mL | Solution/ dropsOphthalmic | 61314-656 | 61314-0656-0561314-0656-1061314-0656-25 | — |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0185-0211 | 00185-0211-01 | — |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 0185-0277 | 00185-0277-01 | — |
| Metolazone | Metolazone 5 mg/1 | TabletOral | 0185-0055 | 00185-0055-0100185-0055-10 | — |
| Metolazone | Metolazone 2.5 mg/1 | TabletOral | 0185-5050 | 00185-5050-0100185-5050-10 | — |
| Metolazone | Metolazone 10 mg/1 | TabletOral | 0185-5600 | 00185-5600-0100185-5600-10 | — |
| Brimonidine Tartrate | Brimonidine tartrate 2 mg/mL | SolutionOphthalmic | 61314-143 | 61314-0143-0561314-0143-1061314-0143-15 | — |
| Digoxin | Digoxin 250 ug/mL | Injection, SolutionIntramuscular, Intravenous, Parenteral | 0781-3059 | 00781-3059-95 | — |
| Infuvite Adultmultiple vitamins injection | — | Kit | 54643-5650 | 54643-5650-02 | — |
| Estradiol Transdermal Systemestradiol | Estradiol .0375 mg/d | PatchTransdermal | 0781-7122 | 00781-7122-54 | — |
| Neomycin and Polymyxin B Sulfates and Hydrocortisoneneomycin sulfate, polymyxin b sulfate and hydrocortisone | Neomycin sulfate 3.5 mg/mL + 2 more ingredients | SuspensionOphthalmic | 61314-641 | 61314-0641-75 | — |
| Moxifloxacin Ophthalmic Solutionmoxifloxacin hydrochloride | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | 0781-7135 | 00781-7135-93 | — |
| Neomycin and Polymyxin B Sulfates and Hydrocortisoneneomycin sulfate, polymyxin b sulfate and hydrocortisone | Neomycin sulfate 3.5 mg/mL + 2 more ingredients | SolutionAuricular (Otic) | 61314-646 | 61314-0646-10 | — |
| Neomycin and Polymyxin B Sulfates and Hydrocortisoneneomycin sulfate, polymyxin b sulfate and hydrocortisone | Neomycin sulfate 3.5 mg/mL + 2 more ingredients | SuspensionAuricular (Otic) | 61314-645 | 61314-0645-11 | — |
| Omeprazole | Omeprazole 10 mg/1 | Capsule, Delayed releaseOral | 0781-2785 | 00781-2785-0100781-2785-1000781-2785-31 | — |
| Omeprazole | Omeprazole 20 mg/1 | Capsule, Delayed releaseOral | 0781-2790 | 00781-2790-0100781-2790-1000781-2790-31+1 more | — |
| Cyclopentolate Hydrochloride | Cyclopentolate hydrochloride 10 mg/mL | SolutionOphthalmic | 61314-396 | 61314-0396-0161314-0396-0261314-0396-03 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 2.5 mg/1 + 3 more ingredients | TabletOral | 0185-0842 | 00185-0842-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 5 mg/1 + 3 more ingredients | TabletOral | 0185-0853 | 00185-0853-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 1.25 mg/1 + 3 more ingredients | TabletOral | 0185-2098 | 00185-2098-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 7.5 mg/1 + 3 more ingredients | TabletOral | 0185-2099 | 00185-2099-01 | — |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 200 mg/5mL; Clavulanate potassium 28.5 mg/5mL | Powder, For suspensionOral | 0781-6102 | 00781-6102-4600781-6102-5200781-6102-57 | — |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 400 mg/5mL; Clavulanate potassium 57 mg/5mL | Powder, For suspensionOral | 0781-6104 | 00781-6104-4600781-6104-5200781-6104-57 | — |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 500 mg/1; Clavulanate potassium 125 mg/1 | Tablet, Film coatedOral | 0781-1831 | 00781-1831-0100781-1831-1300781-1831-20 | — |
| Amoxicillin and Clavulanate Potassium | Amoxicillin 875 mg/1; Clavulanate potassium 125 mg/1 | Tablet, Film coatedOral | 0781-1852 | 00781-1852-0100781-1852-1300781-1852-20 | — |
| Focalindexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 2.5 mg/1 | TabletOral | 66758-250 | 66758-0250-01 | — |
| Focalindexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | TabletOral | 66758-251 | 66758-0251-01 | — |
| Focalindexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | TabletOral | 66758-252 | 66758-0252-01 | — |
| Penicillin G Potassium | Penicillin g potassium 5000000 [iU]/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-6135 | 00781-6135-95 | — |
| Penicillin G Potassium | Penicillin g potassium 20000000 [iU]/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-6136 | 00781-6136-94 | — |
| Trifluridine | Trifluridine 10 mg/mL | SolutionOphthalmic | 61314-044 | 61314-0044-75 | — |
| Penicillin G Sodium | Penicillin g sodium 5000000 [USP'U]/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 0781-6153 | 00781-6153-95 | — |
| Infuvite Pediatricmultiple vitamins injection | — | Kit | 54643-5646 | 54643-5646-01 | — |
| Infuvite Pediatricmultiple vitamins injection | — | Kit | 54643-5647 | 54643-5647-00 | — |
| Lescol XLfluvastatin sodium | Fluvastatin sodium 80 mg/1 | Tablet, Extended releaseOral | 66758-211 | 66758-0211-31 | — |
| Tropicamide | Tropicamide 10 mg/mL | Solution/ dropsOphthalmic | 61314-355 | 61314-0355-0161314-0355-02 | — |
| Tropicamide | Tropicamide 5 mg/mL | Solution/ dropsOphthalmic | 61314-354 | 61314-0354-01 | — |
| Proparacaine Hydrochloride | Proparacaine hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | 61314-016 | 61314-0016-01 | — |
| Betaxolol Hydrochloride | Betaxolol hydrochloride 5.6 mg/mL | Solution/ dropsOphthalmic | 61314-245 | 61314-0245-0161314-0245-0261314-0245-03 | — |
| Orphenadrine Citrate | Orphenadrine citrate 100 mg/1 | Tablet, Extended releaseOral | 0185-0022 | 00185-0022-01 | — |
| Carteolol Hydrochloride | Carteolol hydrochloride 10 mg/mL | SolutionOphthalmic | 61314-238 | 61314-0238-0561314-0238-1061314-0238-15 | — |
| Cromolyn Sodium | Cromolyn sodium 40 mg/mL | Solution/ dropsOphthalmic | 61314-237 | 61314-0237-10 | — |
Sandoz Inc: common questions
- What is Sandoz Inc's NDC labeler code?
- 0781, 61314. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sandoz Inc?
- Med-Code's HCPCS directory matches J1756, J0897, J0135, J3357, J2778, J0131 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.